EFFECTS OF RAMIPRIL, TELMISARTAN AND THEIR COMBINATION ON AMBULATORY BLOOD PRESSURE IN AN ONTARGET SUBSTUDY

被引：0
作者：
Mancia, G. [1 ]
Parati, G. [1 ]
Bilo, G. [1 ]
Giglio, A. [1 ]
Gao, P. [2 ]
Verdecchia, P. [3 ]
Redon, J. [4 ]
Sleight, P. [5 ]
Fagard, R. H. [6 ]
Yusuf, S. [2 ]
Teo, K. [2 ]
机构：
[1] Univ Milano Bicocca, Ist Auxol Italiano, Milan, Italy
[2] McMaster Univ, Hamilton, ON, Canada
[3] Hosp S Maria della Misericordia, Perugia, Italy
[4] Univ Valencia, Valencia, Spain
[5] John Radcliffe Hosp, Oxford OX3 9DU, England
[6] Univ Louvain, Leuven, Belgium
来源：
JOURNAL OF HYPERTENSION | 2009年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
[41]   EFFECTS OF TELMISARTAN, RAMIPRIL AND THEIR COMBINATION ON LEFT VENTRICULAR HYPERTROPHY IN INDIVIDUALS AT HIGH VASCULAR RISK [J].
Verdecchia, P. ;
Sleight, P. ;
Mancia, G. ;
Trimarco, B. ;
Schmieder, R. E. ;
Kim, J. H. ;
Jennings, G. ;
Janscky, P. ;
Chen, J. H. ;
Liu, L. ;
Gao, P. ;
Probstfield, J. ;
Teo, K. ;
Yusuf, S. .
JOURNAL OF HYPERTENSION, 2009, 27 :S166-S166
[42]   Differential effects of telmisartan, ramipril and the combination in renal (pro)renin levels in diabetic rats [J].
Toma, I. ;
Vargas, S. L. ;
Koo, J. J. ;
Peti-Peterdi, J. .
EUROPEAN HEART JOURNAL, 2009, 30 :223-223
[43]   Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating Telmisartan, Ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials [J].
Teo, KK .
AMERICAN HEART JOURNAL, 2004, 148 (01) :52-61
[44]   Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials [J].
Boehm, Michael ;
Baumhaekel, Magnus ;
Teo, Koon ;
Sleight, Peter ;
Probstfield, Jeffrey ;
Gao, Peggy ;
Mann, Johannes F. ;
Diaz, Rafael ;
Dagenais, Gilles R. ;
Jennings, Garry L. R. ;
Liu, Lisheng ;
Jansky, Petr ;
Yusuf, Salim .
CIRCULATION, 2010, 121 (12) :1439-U114
[45]   Chronic effects of telmisartan, ramipril and amlodipine on circadian variations of blood pressure, heart rate and norepinephrine in essential hypertensive patients [J].
de Champlain, J ;
Larochelle, P ;
Lamarre-Cliche, M ;
Lacourcière, Y .
JOURNAL OF HYPERTENSION, 2003, 21 :S226-S226
[46]   Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study [J].
Sleight, Peter ;
Redon, Josep ;
Verdecchia, Paolo ;
Mancia, Giuseppe ;
Gao, Peggy ;
Fagard, Robert ;
Schumacher, Helmut ;
Weber, Michael ;
Boehm, Michael ;
Williams, Bryan ;
Pogue, Janice ;
Koon, Teo ;
Yusuf, Salim .
JOURNAL OF HYPERTENSION, 2009, 27 (07) :1360-1369
[47]   Angioedema due to fixed dose combination of telmisartan plus ramipril [J].
Tandon, Vishal R. ;
Mahajan, Annil ;
Khajuria, Vijay ;
Gillani, Zahid H. .
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2014, 5 (03) :214-216
[48]   ONTARGET proves telmisartan efficacy compared to ramipril in cardiovascular protection of patients at high risk and without heart failure [J].
不详 .
CARDIOVASCULAR JOURNAL OF AFRICA, 2008, 19 (02) :108-109
[49]   The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial [J].
Heerspink, Hiddo J. Lambers ;
Gao, Peggy ;
de Zeeuw, Dick ;
Clase, Catherine ;
Dagenais, Gilles R. ;
Sleight, Peter ;
Lonn, Eva ;
Teo, Koon T. ;
Yusuf, Salim ;
Mann, Johannes F. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (03) :299-309
[50]   EARLY BLOOD PRESSURE CONTROL BY THE NIFEDIPINE GITS/TELMISARTAN COMBINATION [J].
Mancia, G. ;
Parati, G. ;
Bilo, G. ;
Ruilope, L. M. .
JOURNAL OF HYPERTENSION, 2010, 28 :E45-E45
12345